Tarsus Pharmaceuticals Inc. (TARS) Social Stream
TARSUS PHARMACEUTICALS INC (TARS) Price Targets From Analysts
Use the tables below to see what analysts covering TARSUS PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 5 | $67 | $45 | $56.8 | $16.86 | 236.89% |
| 2021-11-23 | 6 | $68 | $45 | $57.166 | $16.86 | 239.06% |
| 2022-03-15 | 7 | $68 | $40 | $54.714 | $16.86 | 224.52% |
| 2022-03-17 | 7 | $69 | $40 | $54.857 | $16.86 | 225.37% |
| 2022-04-18 | 6 | $69 | $40 | $53.714 | $16.86 | 218.59% |
| 2022-05-03 | 7 | $69 | $39 | $55.142 | $16.86 | 227.06% |
| 2022-05-10 | 7 | $69 | $39 | $56.833 | $16.86 | 237.09% |
| 2022-07-09 | 8 | $66 | $40 | $54.714 | $16.86 | 224.52% |
| 2022-08-12 | 8 | $66 | $40 | $52.875 | $16.86 | 213.61% |
| 2022-09-17 | 8 | $66 | $40 | $53 | $16.86 | 214.35% |
| 2022-11-10 | 7 | $66 | $40 | $50.375 | $16.86 | 198.78% |
| 2023-02-08 | 7 | $66 | $40 | $49.333 | $16.86 | 192.6% |
| 2023-03-15 | 7 | $66 | $40 | $48.714 | $16.86 | 188.93% |
| 2023-05-10 | 7 | $65 | $40 | $48.428 | $16.86 | 187.24% |
| 2023-06-15 | 8 | $65 | $40 | $48.428 | $16.86 | 187.24% |
| 2023-06-20 | 8 | $70 | $40 | $49.285 | $16.86 | 192.32% |
| 2023-06-26 | 8 | $70 | $40 | $48.875 | $16.86 | 189.89% |
| 2023-07-17 | 9 | $70 | $40 | $48.875 | $16.86 | 189.89% |
| 2023-07-25 | 9 | $70 | $40 | $48.333 | $16.86 | 186.67% |
| 2023-07-26 | 8 | $70 | $42 | $54.875 | $16.86 | 225.47% |
| 2023-08-02 | 9 | $70 | $42 | $54.875 | $16.86 | 225.47% |
| 2023-08-11 | 7 | $70 | $30 | $48 | $16.86 | 184.7% |
| 2023-08-14 | 7 | $60 | $30 | $46.571 | $16.86 | 176.22% |
| 2023-10-26 | 7 | $60 | $30 | $47.571 | $16.86 | 182.15% |
| 2023-11-13 | 7 | $60 | $30 | $48.142 | $16.86 | 185.54% |
The Trend in the Analyst Price Target
TARS's average price target has moved down $0.29 over the prior 27 weeks.
TARS reports an average of 200.52% for its upside potential over the past 42 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-03 | 7 | 66 | 40 | 48.714 | 14.96 | 225.63% |
| 2023-03-15 | 7 | 66 | 40 | 48.714 | 13.74 | 254.54% |
| 2023-05-08 | 7 | 65 | 40 | 48.428 | 15.59 | 210.64% |
| 2023-06-20 | 8 | 70 | 40 | 48.375 | 19.06 | 153.8% |
| 2023-10-26 | 7 | 60 | 30 | 47.571 | 13.16 | 261.48% |
TARS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 7 | 0 | 0 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
Over the past 52 weeks, TARS's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for TARS as an investment opportunity.
- In the context of all US stocks, TARSUS PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 3150.16% of them.
- To contextualize these metrics, consider that out of all US stocks, TARSUS PHARMACEUTICALS INC's variance in analysts' estimates is lower than -2252.73% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, TARSUS PHARMACEUTICALS INC's average analyst price target is higher than 3392.15% of them.
- In the context of stocks in the small market cap category, TARSUS PHARMACEUTICALS INC's number of analysts covering the stock is greater than 3062.65% of them.
Stocks similar to TARSUS PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ALGS, SRZN, and FDMT.
View All Top Stocks by Price Target
Is TARS a Buy, Hold or Sell? See the POWR Ratings now!